Lung Cancer Stem Cells—Origin, Diagnostic Techniques and Perspective for Therapies

• Main Authors: Agata Raniszewska, Iwona Kwiecień, Elżbieta Rutkowska, Piotr Rzepecki, Joanna Domagała-Kulawik
• Format: Article
• Language: English
• Published: MDPI AG 2021-06-01
• Series: Cancers
• Subjects: non-small lung cancer; cancer stem cells; liquid biopsy; immunotherapy; aging; biopsy
• Online Access: https://www.mdpi.com/2072-6694/13/12/2996

Lung cancer remains one of the most aggressive solid tumors with an overall poor prognosis. Molecular studies carried out on lung tumors during treatment have shown the phenomenon of clonal evolution, thereby promoting the occurrence of a temporal heterogeneity of the tumor. Therefore, the biology of lung cancer is interesting. Cancer stem cells (CSCs) are involved in tumor initiation and metastasis. Aging is still the most important risk factor for lung cancer development. Spontaneously occurring mutations accumulate in normal stem cells or/and progenitor cells by human life resulting in the formation of CSCs. Deepening knowledge of these complex processes and improving early recognition and markers of predictive value are of utmost importance. In this paper, we discuss the CSC hypothesis with an emphasis on age-related changes that initiate carcinogenesis. We analyze the current literature in the field, describe our own experience in CSC investigation and discuss the technical challenges with special emphasis on liquid biopsy.